For Immediate Release

Chicago, IL – June 30, 2010 – Four free stock picks are being made available today on Zacks.com. The industry’s leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and Value.

The four highlighted picks are: CarMax (KMX), CLARCOR Inc. (CLC), Dolby Laboratories, Inc. (DLB) and Medical Action Industries Inc. (MDCI).

Today, Zacks informs investors of its ”Buy” stock recommendations. Four daily picks are offered free at http://at.zacks.com/?id=5607.

Zacks #1 Rank Stocks have nearly tripled the S&P 500 since 1988, producing an average annual return of +28%. Performance has been notable even during volatile and down times. For example, during the last bear market, 2000-2002, the market tumbled -37.6% – but Zacks #1 Rank stocks gained +43.8%.

Here is a summary of today’s selected stocks that are now highly rated by Zacks:

Aggressive Growth – CarMax (KMX)
CarMax was recently added to the S&P 500 after posting its seventh consecutive earnings surprise.

Zacks Guide to Aggressive Growth Investing (free!): http://at.zacks.com/?id=4309

Growth & Income – CLARCOR Inc. (CLC)
CLARCOR Inc. offers investors upside potential from a cyclical economic recovery, while offering some downside protection. The company’s growth is being driven by its engine/mobile business, which is experiencing a strong rebound. CLC’s environmental segment is the market leader in heating, ventilation, air conditioning filtration, navigation fuel filtration, and in-plant filtration, which helps limit the downside during economic slowdowns.

Zacks Guide to Growth & Income Investing (free!): http://at.zacks.com/?id=4310

Momentum – Dolby Laboratories, Inc. (DLB)
Dolby Laboratories, Inc. recently hit a new multi-year high just above $69 as the company continues to expand into growing markets like iTunes, mobile handsets and Blu-ray DVD’s. Even though estimates are on the rise and the next-year estimate is projecting 15% earnings growth, the valuation picture is in line with its industry peers.

Zacks Guide to Momentum Investing (free!): http://at.zacks.com/?id=4311

Value – Medical Action Industries Inc. (MDCI)
Medical Action Industries Inc. has attractive valuations. It is trading at 12.7x earnings which is well under the industry average of 21.3.

Zacks Guide to Value Investing (free!): http://at.zacks.com/?id=4312

How to Regularly Access Top Zacks Rank Picks Free: http://at.zacks.com/?id=7156

Underlying the four free stock picks is a simple truth that first appeared in a Financial Analysts Journal article published in 1979. Leonard Zacks, a Ph.D. in Mathematics from M.I.T. found that “earnings estimate revisions are the most powerful force impacting stock prices.” Zacks #1 Rank is awarded to a stock when analysts sharply upgrade their estimates of what the company will earn.

Today, Zacks releases stock recommendations by offering four daily picks free to those who register at http://at.zacks.com/?id=7157

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. The company continually processes stock reports issued by 3,000 analysts from 150 brokerage firms. It monitors more than 200,000 earnings estimates, looking for changes.

Then, when changes are discovered, they’re applied to help assign more than 4,400 stocks into five Zacks Rank categories: #1 Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This proprietary stock-picking system continues to outperform the market by a nearly 3-to-1 margin.

More Free Stock Picks

Each weekday, new Zacks #1 Rank or Zacks #2 Rank stock picks are released on the free email newsletter, Profit from the Pros. Investors are invited to register for their free subscription at http://at.zacks.com/?id=5642

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Zacks.com

Aggressive Growth Stocks:
Contact: Bill Wilton
Phone: 312-265-9277

or

Growth & Income Stocks:
Contact: Rob Plaza
Phone: 312-265-9442

or

Momentum Stocks:
Contact: Michael Vodicka
Phone: 312-265-9226

or

Value Stocks:
Contact: Tracey Ryniec
Phone: 312-265-9232

Email: pr@zacks.com
Visit: www.zacks.com

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

 

Zacks Investment Research